Raza Muhammad Hassan, Mustafa Awais, Amir Muhammad, Khurram Saleem Muhammad, Ishtiaq Hifza, Akbar Amna, Saleem Khan Mohammad
Gastroenterology, Russells Hall Hospital, Dudley, GBR.
Gastroenterology, Primary and Secondary Healthcare Department, Faisalabad, PAK.
Cureus. 2024 Dec 12;16(12):e75583. doi: 10.7759/cureus.75583. eCollection 2024 Dec.
Jaundice is a state of disease in liver function often along with gastrointestinal (GI) complications primarily characterized by hyperbilirubinemia. Other tests regarding liver function are often used besides bilirubin as during any liver complications biomarkers such as alanine aminotransferase (ALT), serum glutamic pyruvic transaminase (SGPT), aspartate aminotransferase (AST), serum glutamic-oxaloacetic transaminase (SGOT), alkaline phosphatase (ALP), and many other biomarkers even total protein metabolism might get disrupted and get released in the blood. However, no comparison or association among those biomarkers was determined in a cohort. Method: In this observational retrospective cohort study, we investigated the levels of different liver biomarkers and tried to compare their differences and correlations in jaundice patients with GI complications. We examined nine different biomarkers where, primarily, the jaundice was confirmed through the total bilirubin test and further categorized and analyzed them.
Among the 91 patients of the study cohort after bilirubin (n=91) and conjugated bilirubin (n=88) levels, we found that enhanced globulin (n=79) levels were the most dominant among the cohort followed by unconjugated bilirubin (n=76), albumin (n=72), and total protein (n=71). On the other hand, a high ALP level was determined in the lowest number of the population (n=22). Regarding the category of men and women, similar findings were observed with a slight variation as the number of included female patients was approximately six times higher than that of male patients. In the case of age groups, similar observations were determined with some slight variation, as most of the patients were found to be over 40 years of age.
Besides bilirubin, globulin can be a promising biomarker to diagnose jaundice, especially in patients with GI complications. It may also help to indicate the presence of undiagnosed or unsuspected jaundice in patients with gastrointestinal problems.
黄疸是一种肝功能疾病状态,常伴有胃肠道(GI)并发症,主要特征为高胆红素血症。除胆红素外,在任何肝脏并发症期间,还经常使用其他肝功能测试,因为诸如丙氨酸转氨酶(ALT)、血清谷丙转氨酶(SGPT)、天冬氨酸转氨酶(AST)、血清谷草转氨酶(SGOT)、碱性磷酸酶(ALP)等生物标志物,甚至总蛋白代谢可能会受到干扰并释放到血液中。然而,尚未在队列中确定这些生物标志物之间的比较或关联。方法:在这项观察性回顾性队列研究中,我们调查了不同肝脏生物标志物的水平,并试图比较黄疸合并胃肠道并发症患者中它们的差异和相关性。我们检测了九种不同的生物标志物,其中主要通过总胆红素测试确认黄疸,并对其进行进一步分类和分析。
在研究队列的91例患者中,检测了胆红素(n = 91)和结合胆红素(n = 88)水平后,我们发现球蛋白水平升高(n = 79)在队列中最为常见,其次是未结合胆红素(n = 76)、白蛋白(n = 72)和总蛋白(n = 71)。另一方面,人群中碱性磷酸酶水平高的人数最少(n = 22)。在男性和女性类别中,观察到了类似的结果,但有轻微差异,因为纳入的女性患者数量大约是男性患者的六倍。在年龄组方面,也观察到了类似的结果,但有一些轻微差异,因为大多数患者年龄超过40岁。
除胆红素外,球蛋白可能是诊断黄疸的一个有前景的生物标志物,尤其是在伴有胃肠道并发症的患者中。它还可能有助于提示胃肠道问题患者中未被诊断或未被怀疑的黄疸的存在。